The psychological impact of end-stage lung disease

H. K. Singer, R. A. Ruchinskas, K. C. Riley, D. K. Broshek, J. T. Barth

Research output: Contribution to journalArticlepeer-review

64 Scopus citations


Study objectives: End-stage lung disease is associated with poor quality of life and increased risk for psychological distress. Despite the significant number of individuals with end-stage lung diseases, the emotional health of these patients, as compared with those with other chronic organ diseases, is not well-known. The purpose of this article is to elucidate personality styles and the presence of psychopathology in a clinical sample of patients with end-stage lung disease presenting for possible lung transplantation. Design: Cross-sectional survey. Setting: Two academic medical center transplant programs. Participants: Two hundred forty-three consecutively referred transplant candidates. Results: Cluster analysis of the Minnesota Multiphasic Personality Inventory (MMPI)-2 indicated five different personality styles. The majority of patients evidenced mild somatic and depressive symptoms. Approximately one fourth of the sample exhibited marked anxiety and mood disturbances. A small cluster also evidenced features consistent with an antisocial personality style. Conclusions: Separate and distinct personality styles that could affect quality of life, the need for adjunct treatments, and medical compliance emerged from this sample of individuals with end-stage lung disease. Results are discussed in light of prior research on other end-stage organ conditions and in relation to personality and coping theories.

Original languageEnglish (US)
Pages (from-to)1246-1252
Number of pages7
Issue number4
StatePublished - Oct 2001


  • COPD
  • Minnesota multiphasic personality inventory-2
  • Psychopathology

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The psychological impact of end-stage lung disease'. Together they form a unique fingerprint.

Cite this